XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
138 hedge funds and large institutions have $1.18B invested in Acceleron Pharma in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less call options, than puts
Call options by funds: $2.19M | Put options by funds: $2.68M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
138
Holding in Top 10
3
Calls
$2.19M
Puts
$2.68M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$25M | |
| 3 | +$15.1M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.5M |
| 5 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$10.9M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$9.31M | |
| 3 | -$6.62M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.27M |
| 5 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$4.17M |